Conference Abstract
 
Navigation
Conference Abstracts Index

Abstracts - 2006 London

Abstracts - 2005 Zurich

Abstracts - 2004 Berlin

Abstracts - 2003 Barcelona

Abstracts - 2002 Brussels

Abstracts - 2001 Tokyo

Abstracts - 2000 Marburg

       

S6   SOLUBLE FACTORS INVOLVED IN ANDROGEN-MEDIATED EFFECTS ON THE HAIR FOLLICLE

Randall VA., Dept of Biomedical Sciences, University of Bradford, Bradford, BD7 1DP, UK

Androgens regulate many aspects of human hair growth in both sexes.  After puberty they transform tiny vellus follicles in many areas, eg the face, to terminal ones producing long, thick, pigmented hairs.  In genetically predisposed individuals, androgens also cause the reverse transformation of terminal scalp follicles into vellus ones, causing balding.  In the current hypothesis of androgen action, androgens control most follicular cells indirectly acting via the mesenchyme-derived dermal papilla which regulates many aspects of follicular activity.  In this model androgens binding to androgen receptors in dermal papilla cells alter their production of regulatory molecules which influence other follicular components; these molecules may be soluble paracrine factors and/or extracellular matrix proteins.

This hypothesis is supported by immunohistochemical localisation of androgen receptors in dermal papilla cell nuclei and the demonstrations that androgen receptor content and testosterone metabolism patterns of cultured dermal papilla cells from various body sites reflect hair growth in androgen-insensitivity syndromes.  In addition, cultured dermal papilla cells release soluble, proteinaceous factors into their media which stimulate the growth of keratinocytes and other dermal papilla cells. This mitogenic potential can cross species from humans to rodents.  Importantly, testosterone in vitro stimulates the mitogenic potential of beard cells, but in contrast inhibits production by balding scalp cells reflecting their in vivo androgenic responses.

The current focus lies in identifying specific factors eg IGF-1 using ELISA and RT-PCR; this should lead to greater understanding of androgen action and better treatment for androgen-potentiated disorders.